Getty Images The U.S. Food and Drug Administration approved a new drug to treat migraines that’s proven to resolve their pain and other symptoms within two hours, the agency said Friday. The drug, Reyvow, was developed by Eli Lilly and Co. and was proven to be “significantly” more effective than a placebo in halting the… Read More »
FDA Approves Nourianz (istradefylline) as an Add-On Drug to Treat Off Episodes in Adults with Parkinson’s Disease Print this page TOKYO–(BUSINESS WIRE)– August 28, 2019 — Kyowa Kirin Co., Ltd., (Kyowa Kirin, TYO: 4151) announces today that the U.S. Food and Drug Administration (FDA) has granted approval for Nourianz (istradefylline) for use as adjunctive treatment… Read More »
The Food and Drug Administration (FDA) has approved a new drug for the treatment of hypoactive sexual desire disorder in premenopausal women. Bremelanotide (to be marketed as Vyleesi) is used on-demand. Bremelanotide is a peptide which acts as a melanocortin receptor agonist. Its mechanism of action is distinct from flibanserin and is thought to have… Read More »
FDA Approves Dovato (dolutegravir/lamivudine) for HIV-1 Infection Print this page LONDON–(BUSINESS WIRE) April 08, 2019 –ViiV Healthcare today announced that the US Food and Drug Administration (FDA) approved Dovato, a complete, once-daily, single-tablet regimen of dolutegravir (DTG) 50 mg and lamivudine (3TC) 300 mg for the treatment of HIV-1 infection in adults with no antiretroviral… Read More »
Print this page KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Keytruda, Merck’s anti-PD-1 therapy, as monotherapy for the first-line treatment of patients with stage III non-small cell lung cancer (NSCLC) who are not… Read More »